These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14550939)

  • 1. Does estrogen enhance the antidepressant effects of fluoxetine?
    Westlund Tam L; Parry BL
    J Affect Disord; 2003 Oct; 77(1):87-92. PubMed ID: 14550939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women.
    Rasgon NL; Altshuler LL; Fairbanks LA; Dunkin JJ; Davtyan C; Elman S; Rapkin AJ
    J Clin Psychiatry; 2002; 63 Suppl 7():45-8. PubMed ID: 11995778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17β-Estradiol augments antidepressant efficacy of escitalopram in ovariectomized rats: Neuroprotective and serotonin reuptake transporter modulatory effects.
    Ibrahim WW; Safar MM; Khattab MM; Agha AM
    Psychoneuroendocrinology; 2016 Dec; 74():240-250. PubMed ID: 27685339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of tibolone to potentiate the pharmacological effect of fluoxetine in postmenopausal major depression.
    Berlanga C; Mendieta D; Alva G; del Carmen Lara M
    J Womens Health (Larchmt); 2003; 12(1):33-9. PubMed ID: 12639367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine efficacy in menopausal women with and without estrogen replacement.
    Amsterdam J; Garcia-España F; Fawcett J; Quitkin F; Reimherr F; Rosenbaum J; Beasley C
    J Affect Disord; 1999 Sep; 55(1):11-7. PubMed ID: 10512601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the effect of fluoxetine combined with hormone replacement therapy (HRT) and single HRT in treating menopausal depression].
    Yu Q; Yin CX; Hui Y; Yu J; He FF; Wei J; Wu YY
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):461-4. PubMed ID: 15347469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms.
    Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL; Cohen LS
    J Clin Psychiatry; 2003 Apr; 64(4):473-9. PubMed ID: 12716252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mania associated with mirtazapine augmentation of fluoxetine.
    Ng B
    Depress Anxiety; 2002; 15(1):46-7. PubMed ID: 11816053
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.
    Pérez V; Gilaberte I; Faries D; Alvarez E; Artigas F
    Lancet; 1997 May; 349(9065):1594-7. PubMed ID: 9174562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. About the menopausal depression.
    Gaszner P
    Neuropsychopharmacol Hung; 2005 Dec; 7(4):208-14. PubMed ID: 16496486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression.
    Brunello N; Alboni S; Capone G; Benatti C; Blom JM; Tascedda F; Kriwin P; Mendlewicz J
    Int Clin Psychopharmacol; 2006 Jul; 21(4):219-25. PubMed ID: 16687993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid receptor antagonists hasten and augment neurochemical responses to a selective serotonin reuptake inhibitor antidepressant.
    Johnson DA; Grant EJ; Ingram CD; Gartside SE
    Biol Psychiatry; 2007 Dec; 62(11):1228-35. PubMed ID: 17651703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of selective serotonin reuptake inhibitor fluoxetine on symptoms of depression-like behavior in WAG/Rij rats].
    Sarkisova KIu; Folomkina AA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(1):98-108. PubMed ID: 20352689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report.
    Cohen LS; Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL
    Am J Psychiatry; 2003 Aug; 160(8):1519-22. PubMed ID: 12900318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine versus other types of pharmacotherapy for depression.
    Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
    Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadal steroids, selective serotonin reuptake inhibitors, and mood disorders in women.
    Huttner RP; Shepherd JE
    Med Clin North Am; 2003 Sep; 87(5):1065-76. PubMed ID: 14621331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Fluoxetine and Metformin Treatment Potentiates Antidepressant Efficacy Increasing IGF2 Expression in the Dorsal Hippocampus.
    Poggini S; Golia MT; Alboni S; Milior G; Sciarria LP; Viglione A; Matte Bon G; Brunello N; Puglisi-Allegra S; Limatola C; Maggi L; Branchi I
    Neural Plast; 2019; 2019():4651031. PubMed ID: 30804991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes.
    Barbosa L; Berk M; Vorster M
    J Clin Psychiatry; 2003 Apr; 64(4):403-7. PubMed ID: 12716240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic fluoxetine in animal models of anxiety and depression.
    Dulawa SC; Holick KA; Gundersen B; Hen R
    Neuropsychopharmacology; 2004 Jul; 29(7):1321-30. PubMed ID: 15085085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine versus other types of pharmacotherapy for depression.
    Cipriani A; Brambilla P; Furukawa T; Geddes J; Gregis M; Hotopf M; Malvini L; Barbui C
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004185. PubMed ID: 16235353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.